Optimisation of aqueous synthesis of iron oxide nanoparticles for biomedical applications
Source abstract
Abstract
Iron oxide nanoparticles (IONPs) were prepared via aqueous synthesis which combines alkaline co-precipitation (CP) of ferric and ferrous precursors with mild hydrothermal (HT) treatment without cupping agents (CA). In this novel synthesis route, CP + HT, we found the optimal synthesis conditions to obtain IONPs without a second phase and with the size larger than in standard CP: the equal number of Fe(II) and Fe(III) ions are co-precipitated with 6 M ammonia and further HT treated in mild conditions (120 °C for 24 h) without CA. The IONPs obtained by novel CP + HT route had faceted rectangular morphology, a mean TEM diameter of 21.5 ± 6.3 nm, a hydrodynamic diameter of 30.2 ± 9.1 nm and a zeta potential at pH 4 of 48.2 ± 0.6 mV. After the subsequent oxidation step, the final product (IONPs) was studied by XRD, FTIR and XPS, which confirmed the desired structure of γ-Fe2O3. Importantly, this synthesis was especially planned for the preparation of IONPs for biomedical applications. Thus, our novel synthesis was designed to be compliant with the regulations of nano-safety: no special atmosphere, no complex multistep size separation, no organic solvents or solvent exchange, no CA and their washing and the use of low temperature in the final optimised conditions. In addition, this simple synthesis route combines the CP and HT methods, which are both proven to be scalable. Moreover, repeatability and reproducibility of the optimal CP + HT synthesis were confirmed on the lab-scale; more than 100 repetitions with different dishes, different operators and different batches of chemicals were performed.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Iron oxide chemistry and applications · Nanoparticle-Based Drug Delivery · Magnetic Properties and Synthesis of Ferrites
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (53)
Show source-provided references
1. Abu Mukh-Qasem R, Gedanken A (2005) Sonochemical synthesis of stable hydrosol of Fe3O4 nanoparticles. J Colloid Interface Sci 284:489–494. doi: 10.1016/j.jcis.2004.10.07310.1016/j.jcis.2004.10.073 ↗
2. Amiri H, Bustamante R, Millán A et al (2011) Magnetic and relaxation properties of multifunctional polymer-based nanostructured bioferrofluids as MRI contrast agents. Magn Reson Med 66:1715–1721. doi: 10.1002/mrm.2295910.1002/mrm.22959 ↗
3. Baaziz W, Pichon BP, Fleutot S et al (2014) Magnetic iron oxide nanoparticles: reproducible tuning of the size and Nanosized-dependent composition, defects, and spin canting. J Phys Chem C 118:3795–3810. doi: 10.1021/jp411481p10.1021/jp411481p ↗
4. Blanco-Andujar C, Ortega D, Pankhurst QA, Thanh NTK (2012) Elucidating the morphological and structural evolution of iron oxide nanoparticles formed by sodium carbonate in aqueous medium. J Mater Chem 22:12498–12506. doi: 10.1039/C2JM31295F10.1039/C2JM31295F ↗
5. Breeuwsma A, Lyklema J (1971) Interfacial electrochemistry of haematite (α-Fe2O3). Discuss Faraday Soc 52:324–333. doi: 10.1039/DF971520032410.1039/DF9715200324 ↗
6. Bregoli L, Movia D, Gavigan-Imedio JD et al (2016) Nanomedicine applied to translational oncology: a future perspective on cancer treatment. Nanomedicine Nanotechnol Biol Med 12:81–103. doi: 10.1016/j.nano.2015.08.00610.1016/j.nano.2015.08.006 ↗
7. Chastellain M, Petri A, Hofmann H (2004) Particle size investigations of a multistep synthesis of PVA coated superparamagnetic nanoparticles. J Colloid Interface Sci 278:353–360. doi: 10.1016/j.jcis.2004.06.02510.1016/j.jcis.2004.06.025 ↗
8. Cornell RM, Schwertmann U (2003) Introduction to the iron oxides. In: The iron oxides: structure, properties, reactions, occurences and uses. Wiley-VCH Verlag GmbH & Co. KGaA10.1002/3527602097.ch1 ↗
9. Daou TJ, Pourroy G, Bégin-Colin S et al (2006) Hydrothermal synthesis of monodisperse magnetite nanoparticles. Chem Mater 18:4399–4404. doi: 10.1021/cm060805r10.1021/cm060805r ↗
10. Daou TJ, Greneche JM, Pourroy G et al (2008) Coupling agent effect on magnetic properties of functionalized magnetite-based nanoparticles. Chem Mater 20:5869–587510.1021/cm801405n ↗
11. Dirksen JA, Ring TA (1991) Fundamentals of crystallization: kinetic effects on particle size distributions and morphology. Chem Eng Sci 46:2389–2427. doi: 10.1016/0009-2509(91)80035-W10.1016/0009-2509(91)80035-W ↗
12. Etheridge ML, Campbell SA, Erdman AG et al (2013) The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine Nanotechnol Biol Med 9:1–14. doi: 10.1016/j.nano.2012.05.01310.1016/j.nano.2012.05.013 ↗
13. Grosvenor AP, Kobe BA, Biesinger MC, McIntyre NS (2004) Investigation of multiplet splitting of Fe 2p XPS spectra and bonding in iron compounds. Surf Interface Anal 36:1564–1574. doi: 10.1002/sia.198410.1002/sia.1984 ↗
14. Guénin E, Lalatonne Y, Bolley J et al (2014) Catechol versus bisphosphonate ligand exchange at the surface of iron oxide nanoparticles: towards multi-functionalization. J Nanopart Res 16:2596. doi: 10.1007/s11051-014-2596-710.1007/s11051-014-2596-7 ↗
15. Gyergyek S, Makovec D, Jagodič M et al (2017) Hydrothermal growth of iron oxide NPs with a uniform size distribution for magnetically induced hyperthermia: structural, colloidal and magnetic properties. J Alloys Compd 694:261–271. doi: 10.1016/j.jallcom.2016.09.23810.1016/j.jallcom.2016.09.238 ↗
16. Hofmann-Amtenbrink M, Hofmann H, Montet X (2010) Superparamagnetic nanoparticles - a tool for early diagnostics. Swiss Med Wkly. doi: 10.4414/smw.2010.1308110.4414/smw.2010.13081 ↗
17. Hofmann-Amtenbrink M, Hofmann H, Hool A, Roubert F (2014) Nanotechnology in medicine: European research and its implications. Swiss Med Wkly. doi: 10.4414/smw.2014.1404410.4414/smw.2014.14044 ↗
18. Hofmann-Amtenbrink M, Grainger DW, Hofmann H (2015) Nanoparticles in medicine: current challenges facing inorganic nanoparticle toxicity assessments and standardizations. Nanomedicine Nanotechnol Biol Med 11:1689–1694. doi: 10.1016/j.nano.2015.05.00510.1016/j.nano.2015.05.005 ↗
19. Hugounenq P, Levy M, Alloyeau D et al (2012) Iron oxide Monocrystalline Nanoflowers for highly efficient magnetic hyperthermia. J Phys Chem C 116:15702–15712. doi: 10.1021/jp302547810.1021/jp3025478 ↗
20. Hyeon T, Lee SS, Park J et al (2001) Synthesis of highly crystalline and monodisperse maghemite Nanocrystallites without a size-selection process. J Am Chem Soc 123:12798–12801. doi: 10.1021/ja016812s10.1021/ja016812s ↗
21. Jolivet J-P, Chaneac C, Tronc E (2004) Iron oxide chemistry. From molecular clusters to extended solid networks. Chem Commun 481–483. doi: 10.1039/B304532N10.1039/B304532N ↗
22. Kallumadil M, Tada M, Nakagawa T et al (2009) Suitability of commercial colloids for magnetic hyperthermia. J Magn Magn Mater 321:1509–1513. doi: 10.1016/j.jmmm.2009.02.07510.1016/j.jmmm.2009.02.075 ↗
23. Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S (2013) The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med 65:1174–1194. doi: 10.1016/j.freeradbiomed.2013.09.00110.1016/j.freeradbiomed.2013.09.001 ↗
24. Koziej D, Lauria A, Niederberger M (2014) 25th anniversary article: metal oxide particles in materials science: addressing all length scales. Adv Mater 26:235–257. doi: 10.1002/adma.20130316110.1002/adma.201303161 ↗
25. Laurent S, Forge D, Port M et al (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, Vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110. doi: 10.1021/cr068445e10.1021/cr068445e ↗
26. Le Renard P-E, Lortz R, Senatore C et al (2011) Magnetic and in vitro heating properties of implants formed in situ from injectable formulations and containing superparamagnetic iron oxide nanoparticles (SPIONs) embedded in silica microparticles for magnetically induced local hyperthermia. J Magn Magn Mater 323:1054–1063. doi: 10.1016/j.jmmm.2010.12.00310.1016/j.jmmm.2010.12.003 ↗
27. LeFort J (1852) Mémoire sur les oxydes ferroso-ferriques et leurs combinaisons. C R Acad Sci Paris 54:480
28. Lu A-H, Salabas EL, Schüth F (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Ed 46:1222–1244. doi: 10.1002/anie.20060286610.1002/anie.200602866 ↗
29. Mahmoudi M, Hofmann H, Rothen-Rutishauser B, Petri-Fink A (2012) Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem Rev 112:2323–2338. doi: 10.1021/cr200259610.1021/cr2002596 ↗
30. Massart R (1981) Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans Magn 17:1247–1248. doi: 10.1109/TMAG.1981.106118810.1109/TMAG.1981.1061188 ↗
31. Massart R, Cabuil V (1987) Synthèse en milieu alcalin de magnétite colloïdale: contrôle du rendement et de la taille des particules. J Chim Phys 84:967–97310.1051/jcp/1987840967 ↗
32. Massart R, Dubois E, Cabuil V, Hasmonay E (1995) Preparation and properties of monodisperse magnetic fluids. J Magn Magn Mater 149:1–5. doi: 10.1016/0304-8853(95)00316-910.1016/0304-8853(95)00316-9 ↗
33. Maurizi L, Bouyer F, Paris J et al (2011) One step continuous hydrothermal synthesis of very fine stabilized superparamagnetic nanoparticles of magnetite. Chem Commun 47:11706–11708. doi: 10.1039/c1cc15470b10.1039/c1cc15470b ↗
34. Maurizi L, Bouyer F, Ariane M et al (2014) Fast and continuous synthesis of nanostructured iron spinel in supercritical water: influence of cations and citrates. RSC Adv 4:45673–45678. doi: 10.1039/c4ra08562k10.1039/c4ra08562k ↗
35. Micković Z, Alexander DTL, Sienkiewicz A et al (2010) Synthesis of Nanosized Mn-doped ZnO by low temperature decomposition of Hydrozincite precursors. Cryst Growth Des 10:4437–4441. doi: 10.1021/cg100570910.1021/cg1005709 ↗
36. Milosevic I, Jouni H, David C et al (2011) Facile microwave process in water for the fabrication of magnetic Nanorods. J Phys Chem C 115:18999–19004. doi: 10.1021/jp205334v10.1021/jp205334v ↗
37. Milosevic I, Warmont F, Lalatonne Y, Motte L (2014) Magnetic metrology for iron oxide nanoparticle scaled-up synthesis. RSC Adv 4:49086–49089. doi: 10.1039/C4RA08944H10.1039/C4RA08944H ↗
38. Na HB, Song IC, Hyeon T (2009) Inorganic nanoparticles for MRI contrast agents. Adv Mater 21:2133–2148. doi: 10.1002/adma.20080236610.1002/adma.200802366 ↗
39. Neuberger T, Schöpf B, Hofmann H et al (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293:483–496. doi: 10.1016/j.jmmm.2005.01.06410.1016/j.jmmm.2005.01.064 ↗
40. Noh S, Na W, Jang J et al (2012) Nanoscale magnetism control via surface and exchange anisotropy for optimized Ferrimagnetic hysteresis. Nano Lett 12:3716–3721. doi: 10.1021/nl301499u10.1021/nl301499u ↗
41. Okoli C, Sanchez-Dominguez M, Boutonnet M et al (2012) Comparison and functionalization study of microemulsion-prepared magnetic iron oxide nanoparticles. Langmuir 28:8479–8485. doi: 10.1021/la300599q10.1021/la300599q ↗
42. Ozaki M, Kratohvil S, Matijević E (1984) Formation of monodispersed spindle-type hematite particles. J Colloid Interface Sci 102:146–15110.1016/0021-9797(84)90208-X ↗
43. Pascu O, Carenza E, Gich M et al (2012) Surface reactivity of iron oxide nanoparticles by microwave-assisted synthesis; comparison with the thermal decomposition route. J Phys Chem C 116:15108–15116. doi: 10.1021/jp303204d10.1021/jp303204d ↗
44. Petri-Fink A, Hofmann H (2007) Superparamagnetic iron oxide nanoparticles (SPIONs): from synthesis to in vivo studies #×2014; a summary of the synthesis, characterization, in vitro, and in vivo investigations of SPIONs with particular focus on surface and colloidal properties. IEEE Trans NanoBioscience 6:289–297. doi: 10.1109/TNB.2007.90898710.1109/TNB.2007.908987 ↗
45. Petri-Fink A, Chastellain M, Juillerat-Jeanneret L et al (2005) Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26:2685–2694. doi: 10.1016/j.biomaterials.2004.07.02310.1016/j.biomaterials.2004.07.023 ↗
46. Sanz B, Calatayud MP, Cassinelli N et al (2015) Long-term stability and reproducibility of magnetic colloids are key issues for steady values of specific power absorption over time. Eur J Inorg Chem 2015:4524–4531. doi: 10.1002/ejic.20150030310.1002/ejic.201500303 ↗
47. Schwerdt IJ, Goya GF, Calatayud PM et al (2012) Magnetic field-assisted Gene delivery: achievements and therapeutic potential. Curr Gene Ther 12:116–126. doi: 10.2174/15665231280009961610.2174/156652312800099616 ↗
48. Sugimoto T, Matijević E (1980) Formation of uniform spherical magnetite particles by crystallization from ferrous hydroxide gels. J Colloid Interface Sci 74:227–243. doi: 10.1016/0021-9797(80)90187-310.1016/0021-9797(80)90187-3 ↗
49. Tartaj P, Morales MP, Veintemillas-Verdaguer S, et al. (2006) chapter 5 synthesis, properties and biomedical applications of magnetic nanoparticles. In: Buschow KHJ (ed) Handbook of magnetic materials. Elsevier, pp 403–48210.1016/S1567-2719(05)16005-3 ↗
50. Vayssières L, Chanéac C, Tronc E, Jolivet JP (1998) Size tailoring of magnetite particles formed by aqueous precipitation: an example of thermodynamic stability of Nanometric oxide particles. J Colloid Interface Sci 205:205–212. doi: 10.1006/jcis.1998.561410.1006/jcis.1998.5614 ↗
51. Wagner S, Gondikas A, Neubauer E et al (2014) Spot the difference: engineered and natural nanoparticles in the environment—release, behavior, and fate. Angew Chem Int Ed 53:12398–12419. doi: 10.1002/anie.20140505010.1002/anie.201405050 ↗
52. Walter A, Billotey C, Garofalo A et al (2014) Mastering the shape and composition of Dendronized iron oxide nanoparticles to tailor magnetic resonance imaging and hyperthermia. Chem Mater 26:5252–5264. doi: 10.1021/cm501902510.1021/cm5019025 ↗
53. Wu W, Wu Z, Yu T et al (2015) Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications. Sci Technol Adv Mater 16:23501. doi: 10.1088/1468-6996/16/2/02350110.1088/1468-6996/16/2/023501 ↗